John Magulick, MD
Gastroenterology · Pensacola, FLNPI 1356668271
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (44.9%), education and food and beverage — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Ovesco Endoscopy USA, Inc. at 44.9% of the total. Reporting peaked in 2024 at $722 and has fallen 86.0% since, to $101 in 2025. That places this record below the midpoint for gastroenterology clinicians in FL, where the typical reported total is $3,025.
Across 11 payments — averaging $146.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ovesco Endoscopy USA, Inc.$722
- Boston Scientific$630
- Olympus America Inc.$124
- Takeda Pharmaceuticals U.S.A., Inc.$33
- Cook Medical LLC$29
- Ardelyx, Inc.$26
- plus $42 from 2 others
What the payments were for
- Travel & lodging$72245%
- Food & beverage$33721%
- Education$54834%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ovesco Endoscopy USA, Inc. | 1 | $722 |
| Boston Scientific | 3 | $630 |
| Olympus America Inc. | 1 | $124 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Cook Medical LLC | 1 | $29 |
| Ardelyx, Inc. | 1 | $26 |
| Novo Nordisk | 1 | $21 |
| AbbVie | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,607 in reported general payments places this provider in the 35th percentile of 1,388 gastroenterology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 17 | $1,047 |
| Omeprazole | 16 | $642 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Pensacola
- Samuel GidayOrlando$2M
- Lukasz KwapiszMiami$1.2M
- Jennifer Seminerio-DiehlOrlando$1.1M
- Udayakumar NavaneethanSaint Petersburg$1.1M
- Ronen AraiCoral Springs$1.1M
- Charles SninskyGainesville$983K
- Peter DraganovGainesville$832K
- Arin NewmanMiami Beach$716K
- Joanna LopezMiami$670K
- Jose NietoSebring$573K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.